Target Market Opportunity Circuport serves the 1.5 million global hemodialysis patients and targets over 100,000 individuals currently relying on traditional catheters. This presents a sizable addressable market for a safer implantable vascular access solution, with potential for high impact in reducing complications and healthcare costs.

Clinical Impact Benefit The patented implantable port is designed to reduce infections and thrombosis from dialysis catheters, aiming to improve patient quality of life and cut healthcare costs by over a billion dollars annually, which can be a strong value proposition for hospital systems and payers.

Early Adoption Readiness With a disposable needle enabling safe, repeated vascular access (3x per week), Circuport aligns with existing dialysis workflows and could be positioned as an incremental innovation for clinics seeking to lower complication rates and readmission risks.

Strategic Partnerships Potential sales opportunities exist with large hospital networks, dialysis centers, and medical device distributors seeking safer access solutions, as well as collaborations with vascular surgeons and nephrology departments to drive trials and reimbursement discussions.

Go-To-Market Readiness Current revenue is modest, suggesting a need for phased pilots, regulatory clearance, and evidence generation. Emphasize cost savings, patient outcomes, and total cost of care in pitches to secure early adopters and payor support.